Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NIMESULIDE CRS (100 MG)

NIMESULIDE CRS (100 MG)

51803-78-2

DISCOVER
NIMESULIDE IMPURITY D CRS (0.004 MG)

NIMESULIDE IMPURITY D CRS (0.004 MG)

NA

DISCOVER
NIMODIPINE CRS (50 MG)

NIMODIPINE CRS (50 MG)

66085-59-4

DISCOVER
NIMODIPINE IMPURITY A CRS (1 ML)

NIMODIPINE IMPURITY A CRS (1 ML)

NA

DISCOVER
Nitroxinil

Nitroxinil

1689-89-0

DISCOVER
Nornicotine

Nornicotine

5746-86-1

DISCOVER
Niflumic acid

Niflumic acid

4394-00-7

DISCOVER
NITRAZEPAM CRS - * PSY (100 MG)

NITRAZEPAM CRS - * PSY (100 MG)

ND

DISCOVER
NITRENDIPINE CRS (60 MG)

NITRENDIPINE CRS (60 MG)

ND

DISCOVER
NITRENDIPINE IMPURITY A CRS (35 MG)

NITRENDIPINE IMPURITY A CRS (35 MG)

ND

DISCOVER
NITRIC OXIDE - REFERENCE SPECTRUM (N/A)

NITRIC OXIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
NITROFURAL CRS (160 MG)

NITROFURAL CRS (160 MG)

59-87-0

DISCOVER